These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29979514)

  • 41. Novel Diketopiperazine Dihydroorotate Dehydrogenase Inhibitors Purified from Traditional Tibetan Animal Medicine Osteon Myospalacem Baileyi.
    Jiang L; Wen H; Shao Y; Yu R; Liu Z; Wang S; Wang Q; Zhao X; Zhang P; Tao Y; Mei L
    Chem Biol Drug Des; 2015 Oct; 86(4):626-36. PubMed ID: 25626527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QSAR study on a series of aryl carboxylic acid amide derivatives as potential inhibitors of dihydroorotate dehydrogenase (DHODH).
    Vyas VK; Ghate M
    Med Chem; 2013 Mar; 9(2):222-39. PubMed ID: 22920152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
    Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
    Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-
    Sainas S; Giorgis M; Circosta P; Gaidano V; Bonanni D; Pippione AC; Bagnati R; Passoni A; Qiu Y; Cojocaru CF; Canepa B; Bona A; Rolando B; Mishina M; Ramondetti C; Buccinnà B; Piccinini M; Houshmand M; Cignetti A; Giraudo E; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML
    J Med Chem; 2021 May; 64(9):5404-5428. PubMed ID: 33844533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liquid phase combinatorial synthesis of 1,2,5-trisubstituted benzimidazole derivatives as human DHODH inhibitors.
    Sitwala ND; Vyas VK; Variya BC; Patel SS; Mehta CC; Rana DN; Ghate MD
    Bioorg Chem; 2017 Dec; 75():118-126. PubMed ID: 28941392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives.
    Xu M; Zhu J; Diao Y; Zhou H; Ren X; Sun D; Huang J; Han D; Zhao Z; Zhu L; Xu Y; Li H
    J Med Chem; 2013 Oct; 56(20):7911-24. PubMed ID: 24073986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
    Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
    Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors.
    Chilingaryan G; Abelyan N; Sargsyan A; Nazaryan K; Serobian A; Zakaryan H
    Sci Rep; 2021 Jun; 11(1):11417. PubMed ID: 34075175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase.
    Xie W; Zhang H; He J; Zhang J; Yu Q; Luo C; Li S
    Bioorg Med Chem Lett; 2017 Feb; 27(3):530-532. PubMed ID: 28011217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain.
    Pinheiro MP; Iulek J; Cristina Nonato M
    Biochem Biophys Res Commun; 2008 May; 369(3):812-7. PubMed ID: 18302934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.
    Fang Z; Kang D; Zhang L; Huang B; Liu H; Pannecouque C; De Clercq E; Zhan P; Liu X
    Chem Biol Drug Des; 2015 Oct; 86(4):614-8. PubMed ID: 25626467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold.
    Lolli ML; Giorgis M; Tosco P; Foti A; Fruttero R; Gasco A
    Eur J Med Chem; 2012 Mar; 49():102-9. PubMed ID: 22245049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme inhibition potency enhancement by active site metal chelating and hydrogen bonding induced conformation-restricted cyclopropanecarbonyl derivatives.
    Kuo PY; Shie TL; Chen YS; Lai JT; Yang DY
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6024-7. PubMed ID: 16979340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability.
    Popova G; Ladds MJGW; Johansson L; Saleh A; Larsson J; Sandberg L; Sahlberg SH; Qian W; Gullberg H; Garg N; Gustavsson AL; Haraldsson M; Lane D; Yngve U; Lain S
    J Med Chem; 2020 Apr; 63(8):3915-3934. PubMed ID: 32212728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative structure-activity relationships for phenyl triazolinones of protoporphyrinogen oxidase inhibitors: a density functional theory study.
    Wan J; Zhang L; Yang G
    J Comput Chem; 2004 Nov; 25(15):1827-32. PubMed ID: 15389747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities.
    Lu K; Zhao Y; Wu G; Hu H; Wang M; Gong G; Jiang Y
    Bioorg Chem; 2019 May; 86():44-51. PubMed ID: 30685643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
    Hurt DE; Sutton AE; Clardy J
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1610-5. PubMed ID: 16406782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors.
    Sato T; Ashizawa N; Iwanaga T; Nakamura H; Matsumoto K; Inoue T; Nagata O
    Bioorg Med Chem Lett; 2009 Jan; 19(1):184-7. PubMed ID: 19027292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening.
    Pavadai E; El Mazouni F; Wittlin S; de Kock C; Phillips MA; Chibale K
    J Chem Inf Model; 2016 Mar; 56(3):548-62. PubMed ID: 26915022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.
    Leban J; Kralik M; Mies J; Baumgartner R; Gassen M; Tasler S
    Bioorg Med Chem Lett; 2006 Jan; 16(2):267-70. PubMed ID: 16246558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.